Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D W Dodick

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
Neurology|March 2, 2012
Randomized, placebo-controlled trial of propranolol added to topiramate in chronic migraineS D Silberstein, D W Dodick, A S Lindblad, et al.
Cephalalgia : an International Journal of Headache|March 27, 2007
Treatment-emergent CNS symptoms following triptan therapy are part of the attackP J Goadsby, D W Dodick, M Almas, et al.
Neurology|March 11, 2009
ACGME competencies in neurology: web-based objective simulated computerized clinical encountersK M Kash, B F Leas, J Clough, et al.
Journal of Neurology|March 12, 2005
The use of multiattribute decision models in evaluating triptan treatment options in migraineM D Ferrari, P J Goadsby, R B Lipton, et al.
European Journal of Neurology|March 18, 2014
Pooled analysis of the safety and tolerability of onabotulinumtoxinA in the treatment of chronic migraineH-C Diener, D W Dodick, C C Turkel, et al.
Acta Neurologica Scandinavica|October 11, 2013
OnabotulinumtoxinA for chronic migraine: efficacy, safety, and tolerability in patients who received all five treatment cycles in the PREEMPT clinical programS K Aurora, D W Dodick, H-C Diener, et al.
Cephalalgia : an International Journal of Headache|February 18, 2009
Consistency of response to sumatriptan/naproxen sodium in a placebo-controlled, crossover studyR B Lipton, D W Dodick, J U Adelman, et al.
Current Medical Research and Opinion|April 7, 2005
How treatment priorities influence triptan preferences in clinical practice: perspectives of migraine sufferers, neurologists, and primary care physiciansR B Lipton, F M Cutrer, P J Goadsby, et al.
Cephalalgia : an International Journal of Headache|July 22, 2010
OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trialH C Diener, D W Dodick, S K Aurora, et al.
Cephalalgia : an International Journal of Headache|July 22, 2010
OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trialS K Aurora, D W Dodick, C C Turkel, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
Neurology|March 2, 2012
Randomized, placebo-controlled trial of propranolol added to topiramate in chronic migraineS D Silberstein, D W Dodick, A S Lindblad, et al.
Cephalalgia : an International Journal of Headache|March 27, 2007
Treatment-emergent CNS symptoms following triptan therapy are part of the attackP J Goadsby, D W Dodick, M Almas, et al.
Neurology|March 11, 2009
ACGME competencies in neurology: web-based objective simulated computerized clinical encountersK M Kash, B F Leas, J Clough, et al.
Journal of Neurology|March 12, 2005
The use of multiattribute decision models in evaluating triptan treatment options in migraineM D Ferrari, P J Goadsby, R B Lipton, et al.
European Journal of Neurology|March 18, 2014
Pooled analysis of the safety and tolerability of onabotulinumtoxinA in the treatment of chronic migraineH-C Diener, D W Dodick, C C Turkel, et al.
Acta Neurologica Scandinavica|October 11, 2013
OnabotulinumtoxinA for chronic migraine: efficacy, safety, and tolerability in patients who received all five treatment cycles in the PREEMPT clinical programS K Aurora, D W Dodick, H-C Diener, et al.
Cephalalgia : an International Journal of Headache|February 18, 2009
Consistency of response to sumatriptan/naproxen sodium in a placebo-controlled, crossover studyR B Lipton, D W Dodick, J U Adelman, et al.
Current Medical Research and Opinion|April 7, 2005
How treatment priorities influence triptan preferences in clinical practice: perspectives of migraine sufferers, neurologists, and primary care physiciansR B Lipton, F M Cutrer, P J Goadsby, et al.
Cephalalgia : an International Journal of Headache|July 22, 2010
OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trialH C Diener, D W Dodick, S K Aurora, et al.
Cephalalgia : an International Journal of Headache|July 22, 2010
OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trialS K Aurora, D W Dodick, C C Turkel, et al.
Pageof 8